His scientific interests lie mostly in Internal medicine, Cardiology, Heart failure, Myocardial infarction and Surgery. When carried out as part of a general Cardiology research project, his work on Coronary artery disease, Stroke volume, Ventricular remodeling and Coronary artery bypass surgery is frequently linked to work in In patient, therefore connecting diverse disciplines of study. His Coronary artery disease research includes elements of Ischemia and Ischemic cardiomyopathy.
His Heart failure research is multidisciplinary, incorporating perspectives in Valsartan, Circulatory system, Heart disease and Renal function. His Myocardial infarction research is multidisciplinary, relying on both ACE inhibitor and Sudden death. His Ejection fraction research incorporates themes from Placebo and Hyperkalemia.
Eric J. Velazquez mostly deals with Internal medicine, Cardiology, Heart failure, Ejection fraction and Myocardial infarction. His work in the fields of Internal medicine, such as Coronary artery disease, Valsartan and Hazard ratio, overlaps with other areas such as In patient. The study of Cardiology is intertwined with the study of Proportional hazards model in a number of ways.
In his study, which falls under the umbrella issue of Heart failure, Sacubitril, Valsartan is strongly linked to Enalapril. His study in Ejection fraction is interdisciplinary in nature, drawing from both Mitral regurgitation, Sudden cardiac death and Diastole. Eric J. Velazquez works mostly in the field of Myocardial infarction, limiting it down to topics relating to Stroke and, in certain cases, Atrial fibrillation.
Eric J. Velazquez spends much of his time researching Internal medicine, Cardiology, Heart failure, Ejection fraction and Sacubitril, Valsartan. Eric J. Velazquez frequently studies issues relating to Valsartan and Cardiology. His work in the fields of Natriuretic peptide overlaps with other areas such as In patient.
Eric J. Velazquez has researched Ejection fraction in several fields, including Retrospective cohort study, Cohort and Renal function. In Sacubitril, Valsartan, Eric J. Velazquez works on issues like Enalapril, which are connected to Brain natriuretic peptide. His Coronary artery disease study integrates concerns from other disciplines, such as Heart disease and New onset.
Eric J. Velazquez mainly focuses on Internal medicine, Heart failure, Cardiology, Ejection fraction and Coronary artery disease. His work on Sacubitril, Valsartan as part of general Heart failure study is frequently connected to In patient, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His Cardiology study frequently involves adjacent topics like Adverse effect.
His Ejection fraction research focuses on Quality of life and how it connects with Quality-adjusted life year, Etiology, Proportional hazards model and Emergency medicine. As a member of one scientific family, Eric J. Velazquez mostly works in the field of Coronary artery disease, focusing on Artery and, on occasion, Ischemia, Revascularization, Percutaneous coronary intervention and Conventional PCI. His Enalapril research focuses on subjects like Valsartan, which are linked to Randomized controlled trial.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
Marc A. Pfeffer;John J.V. McMurray;Eric J. Velazquez;Jean-Lucien Rouleau.
The New England Journal of Medicine (2003)
Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients
Kenneth Jamerson;Michael A. Weber;George L. Bakris;Björn Dahlöf.
The New England Journal of Medicine (2008)
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
Nagesh S Anavekar;John J V McMurray;Eric J Velazquez;Scott D Solomon.
The New England Journal of Medicine (2004)
Diuretic Strategies in Patients with Acute Decompensated Heart Failure
G. Michael Felker;Kerry L. Lee;David A. Bull;Margaret M. Redfield.
The New England Journal of Medicine (2011)
Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction
Eric J. Velazquez;Kerry L. Lee;Marek A. Deja;Anil Jain.
The New England Journal of Medicine (2011)
Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease
Pamela S. Douglas;Udo Hoffmann;Manesh R. Patel;Daniel B. Mark.
The New England Journal of Medicine (2015)
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: A randomized clinical trial
Margaret M. Redfield;Horng H. Chen;Barry A. Borlaug;Marc J. Semigran.
JAMA (2013)
Ultrafiltration in decompensated heart failure with cardiorenal syndrome
Bradley A. Bart;Steven R. Goldsmith;Kerry L. Lee;Michael M. Givertz.
The New England Journal of Medicine (2012)
Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both
Scott D. Solomon;Steve Zelenkofske;John J.V. McMurray;Peter V. Finn.
The New England Journal of Medicine (2005)
Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction
Robert O. Bonow;Gerald Maurer;Kerry L. Lee;Thomas A. Holly.
The New England Journal of Medicine (2011)
University of Glasgow
Brigham and Women's Hospital
Duke University
Brigham and Women's Hospital
Duke University
Copenhagen University Hospital
Duke University
Heart Care Foundation, ANMCO Research Center, Florence
Duke University
Auckland City Hospital
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: